Allspring Global Investments Holdings LLC Sells 170 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Allspring Global Investments Holdings LLC lowered its position in The Cooper Companies, Inc. (NASDAQ:COO) by 1.7% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 9,862 shares of the medical device company’s stock after selling 170 shares during the quarter. Allspring Global Investments Holdings LLC’s holdings in Cooper Companies were worth $861,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in the business. Franklin Resources Inc. lifted its position in Cooper Companies by 1.2% during the fourth quarter. Franklin Resources Inc. now owns 3,401 shares of the medical device company’s stock valued at $1,287,000 after purchasing an additional 41 shares during the last quarter. KLR Investment Advisors LLC grew its position in Cooper Companies by 4.3% in the fourth quarter. KLR Investment Advisors LLC now owns 1,117 shares of the medical device company’s stock worth $423,000 after acquiring an additional 46 shares in the last quarter. Quadrant Capital Group LLC increased its stake in Cooper Companies by 10.8% in the fourth quarter. Quadrant Capital Group LLC now owns 613 shares of the medical device company’s stock valued at $232,000 after acquiring an additional 60 shares during the last quarter. Westpac Banking Corp raised its position in Cooper Companies by 18.8% during the fourth quarter. Westpac Banking Corp now owns 543 shares of the medical device company’s stock valued at $205,000 after purchasing an additional 86 shares in the last quarter. Finally, Lincoln National Corp boosted its holdings in shares of Cooper Companies by 13.9% in the 4th quarter. Lincoln National Corp now owns 768 shares of the medical device company’s stock worth $291,000 after purchasing an additional 94 shares in the last quarter. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Analysts Set New Price Targets

A number of analysts recently weighed in on the company. Piper Sandler boosted their target price on Cooper Companies from $115.00 to $120.00 and gave the stock an “overweight” rating in a research report on Thursday, August 29th. Robert W. Baird lifted their price target on shares of Cooper Companies from $118.00 to $125.00 and gave the stock an “outperform” rating in a research note on Thursday, August 29th. Needham & Company LLC reaffirmed a “hold” rating on shares of Cooper Companies in a report on Thursday, August 29th. Stifel Nicolaus reiterated a “buy” rating and issued a $115.00 target price (up previously from $110.00) on shares of Cooper Companies in a research report on Thursday, August 29th. Finally, Wells Fargo & Company upped their price target on shares of Cooper Companies from $110.00 to $115.00 and gave the company an “overweight” rating in a research report on Thursday, August 29th. Four analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $113.61.

Cooper Companies Stock Down 0.5 %

Shares of NASDAQ:COO opened at $105.54 on Thursday. The stock’s 50-day moving average is $92.54 and its 200 day moving average is $94.47. The company has a market cap of $21.02 billion, a PE ratio of 61.99, a P/E/G ratio of 2.56 and a beta of 0.98. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.99 and a quick ratio of 1.14. The Cooper Companies, Inc. has a 1 year low of $75.93 and a 1 year high of $107.46.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Wednesday, August 28th. The medical device company reported $0.96 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.91 by $0.05. Cooper Companies had a return on equity of 9.08% and a net margin of 9.45%. The firm had revenue of $1 billion for the quarter, compared to analysts’ expectations of $997.30 million. During the same period in the previous year, the firm earned $0.84 earnings per share. The business’s revenue was up 7.8% compared to the same quarter last year. Sell-side analysts anticipate that The Cooper Companies, Inc. will post 3.66 EPS for the current year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.